|
nasdaq:ptct
|
22324
|
Apr 28th, 2024 12:00AM
|
PTC Therapeutics, Inc.
|
64K
|
1190
|
Open
|
|
Apr 27th, 2024 11:53PM
|
Apr 27th, 2024 11:53PM
|
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease.
|
Open
|
Orphan and Ultra-orphan Disorders, Oncology, and Anti-infectives
|
Open
|
|
|
|
US
|
|
|
PTC Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:ptct
|
22324
|
Apr 27th, 2024 12:00AM
|
PTC Therapeutics, Inc.
|
64K
|
1191
|
Open
|
|
Apr 26th, 2024 11:32PM
|
Apr 26th, 2024 11:32PM
|
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease.
|
Open
|
Orphan and Ultra-orphan Disorders, Oncology, and Anti-infectives
|
Open
|
|
|
|
US
|
|
|
PTC Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:ptct
|
22324
|
Apr 26th, 2024 12:00AM
|
PTC Therapeutics, Inc.
|
64K
|
1195
|
Open
|
|
Apr 25th, 2024 11:40PM
|
Apr 26th, 2024 09:00AM
|
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease.
|
Open
|
Orphan and Ultra-orphan Disorders, Oncology, and Anti-infectives
|
Open
|
|
|
|
US
|
|
|
PTC Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:ptct
|
22324
|
Apr 25th, 2024 12:00AM
|
PTC Therapeutics, Inc.
|
64K
|
1195
|
Open
|
|
Apr 24th, 2024 11:34PM
|
Apr 25th, 2024 07:13PM
|
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease.
|
Open
|
Orphan and Ultra-orphan Disorders, Oncology, and Anti-infectives
|
Open
|
|
|
|
US
|
|
|
PTC Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:ptct
|
22324
|
Apr 24th, 2024 12:00AM
|
PTC Therapeutics, Inc.
|
64K
|
1195
|
Open
|
|
Apr 23rd, 2024 11:42PM
|
Apr 24th, 2024 11:42AM
|
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease.
|
Open
|
Orphan and Ultra-orphan Disorders, Oncology, and Anti-infectives
|
Open
|
|
|
|
US
|
|
|
PTC Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:ptct
|
22324
|
Apr 23rd, 2024 12:00AM
|
PTC Therapeutics, Inc.
|
64K
|
1195
|
Open
|
|
Apr 22nd, 2024 11:23PM
|
Apr 23rd, 2024 05:15PM
|
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease.
|
Open
|
Orphan and Ultra-orphan Disorders, Oncology, and Anti-infectives
|
Open
|
|
|
|
US
|
|
|
PTC Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:ptct
|
22324
|
Apr 22nd, 2024 12:00AM
|
PTC Therapeutics, Inc.
|
64K
|
1196
|
Open
|
|
Apr 22nd, 2024 12:02AM
|
Apr 22nd, 2024 12:02AM
|
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease.
|
Open
|
Orphan and Ultra-orphan Disorders, Oncology, and Anti-infectives
|
Open
|
|
|
|
US
|
|
|
PTC Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:ptct
|
22324
|
Apr 21st, 2024 12:00AM
|
PTC Therapeutics, Inc.
|
64K
|
1198
|
Open
|
|
Apr 20th, 2024 11:59PM
|
Apr 20th, 2024 11:59PM
|
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease.
|
Open
|
Orphan and Ultra-orphan Disorders, Oncology, and Anti-infectives
|
Open
|
|
|
|
US
|
|
|
PTC Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:ptct
|
22324
|
Apr 20th, 2024 12:00AM
|
PTC Therapeutics, Inc.
|
64K
|
1198
|
Open
|
|
Apr 19th, 2024 11:56PM
|
Apr 20th, 2024 05:31PM
|
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease.
|
Open
|
Orphan and Ultra-orphan Disorders, Oncology, and Anti-infectives
|
Open
|
|
|
|
US
|
|
|
PTC Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:ptct
|
22324
|
Apr 19th, 2024 12:00AM
|
PTC Therapeutics, Inc.
|
64K
|
1197
|
Open
|
|
Apr 19th, 2024 12:04AM
|
Apr 19th, 2024 12:04AM
|
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease.
|
Open
|
Orphan and Ultra-orphan Disorders, Oncology, and Anti-infectives
|
Open
|
|
|
|
US
|
|
|
PTC Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|